Edition:
United States

Hot Stocks Headlines

Kite CAR-T gets FDA priority review, Juno shares fall

Kite Pharma Inc on Friday said the U.S. Food and Drug Administration will review its experimental drug axicabtagene ciloleucel on a priority basis as a treatment for advanced non-Hodgkin lymphoma, a cancer that starts in white blood cells.

Earlier
Photo

Trump attacks 'fake news' following Kushner reports

WASHINGTON U.S. President Donald Trump attacked the news media and dismissed leaks from the White House as "fake news" on Sunday, following reports his son-in-law tried to set up a secret channel of communications with Moscow before Trump took office. | Video